Press Releases

Sydney, Aug 19, 2011 (ABN Newswire) - SmartTrans Holdings Limited (ASX:SMA) has signed a binding agreement with China Mobile (HKG:0941) (NYSE:CHL) that allows SmartTrans to collect payment from China Mobile customers. China Mobile's users will be able to buy SmartTrans products including SmartTrans e-Solution logistics software and other content, on their mobile telephones and pay via their China Mobile CMPay account. China Mobile's CMPay is a mobile payment service that allows users to conduct e-commerce operations though their mobile phone, such as payments, recharging, transferring or enquiries.

Golden Rim Resources Limited (ASX:GMR) today announced copper and gold intersections from the second program of reverse circulation drilling at its Balogo Project in Burkina Faso. Best new intersections included 14m at 2.56 g/t gold and 4m at 3.02 g/t gold. A second major mineralised zone with high-grade gold has been discovered. A further 1.3km of strike with strong anomalies has been confirmed and will be tested by drilling.

Highlands Pacific Limited (ASX:HIG) said today that its fully constructed US$1.5 billion Ramu Nickel project in Papua New Guinea will commence ore commissioning activities at the Basamuk treatment plant in September. The project should commission its first autoclave in coming months and produce its first nickel and cobalt in the weeks after as part of a conservative ramp up over the next 12-18 months. The project is targeting a production rate of 31,150 tpa of nickel and 3,300 tpa of cobalt over the next 20 years.

Aquila Resources Limited (ASX:AQA) said today that the Queensland Government has granted the Mining Lease for the Eagle Downs Hard Coking Coal Project in Central Queensland. The Project involves proposed construction, development and operation of an underground hard coking coal mine in Queensland's resource-rich Bowen Basin. When in production the mine will be producing up to 5.1Mtpa and an average of 4.5Mtpa of hard coking coal over the initial 10 years of production.

Suven Life Sciences Limited (BOM:530239) has been granted 4 product patents, one from Europe, two from Sri Lanka, and one from Korea, for the treatment of Neurodegenerative disorders such as Alzheimer's disease, Attention Deficient Hyperactivity Disorder, Huntington's disease, Parkinson and Schizophrenia. With these new patents, the company has a total of 11 granted patents from Europe, 8 granted patents from Sri Lanka and 5 granted patents from Korea.

Contact

Asia Business News Sydney Tel: +61-2-9247-4344 Tokyo Tel: +81-3-6868-3802 http://www.abnnewswire.net